Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Pregnancy and Childbirth
Published in: BMC Pregnancy and Childbirth 1/2020

Open Access 01-12-2020 | Research article

Distribution of maternal red cell antibodies and the risk of severe alloimmune haemolytic disease of the foetus in a Chinese population: a cohort study on prenatal management

Authors: Si Li, Zhiming He, Yanmin Luo, Yanli Ji, Guangping Luo, Qun Fang, Yu Gao

Published in: BMC Pregnancy and Childbirth | Issue 1/2020

Login to get access

Abstract

Background

Haemolytic disease of the foetus and newborn (HDFN) is the most common aetiology of haemolytic anaemia and hyperbilirubinaemia in foetuses and neonates. Studies on the distribution of antibodies that cause haemolytic disease of the foetus (HDF) in China are limited, and the effects of multiple antibodies on the severity of HDF need further evaluation.

Methods

An observational cohort study from January 2005 to December 2019 was conducted in two hospitals affiliated with Sun Yat-sen University. Maternal red cell alloimmunization was identified by the Guangzhou Blood Centre. In total, 268 pregnant woman-foetus pairs were divided into four groups according to the type of maternal alloantibodies: anti-D, anti-D combined with other antibodies, other single-antibody and other multiple antibodies. The obstetric history, antibody characteristics, incidence of severe HDF and foetal outcomes were collected and compared. Logistic regression analysis of the risk factors for HDF and survival analysis of the severe HDF-free interval were conducted.

Results

Anti-D was the most common cause of HDF, followed by anti-M. No anti-K- or isolated anti-c-associated HDF was found. The incidence of severe HDF was higher in the group with anti-D combined with other antibodies than in the group with anti-D alone (P = 0.025), but no significant difference was found in haemoglobin level and reticulocyte count in the anaemic foetuses between these two groups. Foetuses in the other single-antibody group had a lower reticulocyte count (P = 0.007), more IUTs (P = 0.007) and an earlier onset of severe HDF (P = 0.012). The maximum antibody titre was significantly lower in the other single-antibody group than in the anti-D group (P < 0.001). A high maternal antibody titre (P < 0.001), multiple affected pregnancies (P < 0.001) and other single-antibody (P = 0.042) were independent risk factors for HDF. A higher reticulocyte count (P = 0.041) was an independent risk factor for severe HDF in anaemia foetuses affected by Rh(D) alloimmunization.

Conclusions

The distribution of HDF-associated antibodies in China is different from that in Western countries. Other single non-Rh(D) antibodies could increase the risk of HDF, and anti-D combined with other antibodies would not influence the severity of foetal anaemia compared with anti-D alone.
Literature
1.
de Haas M, Thurik FF, Koelewijn JM, van der Schoot CE. Haemolytic disease of the fetus and newborn. Vox Sang. 2015;109(2):99–113.PubMedCrossRef
2.
de Haas M, Finning K, Massey E, Roberts DJ. Anti-D prophylaxis: past, present and future. Transfus Med. 2014;24(1):1–7.PubMedCrossRef
3.
Qureshi H, Massey E, Kirwan D, Davies T, Robson S, White J, Jones J, Allard S. BCSH guideline for the use of anti-D immunoglobulin for the prevention of haemolytic disease of the fetus and newborn. Transfus Med. 2014;24(1):8–20.PubMedCrossRef
4.
Chandrasekar A, Morris KG, Tubman TR, Tharma S, McClelland WM. The clinical outcome of non-RhD antibody affected pregnancies in Northern Ireland. Ulster Med J. 2001;70(2):89–94.PubMedPubMedCentral
5.
Koelewijn JM, Vrijkotte TGM, van der Schoot CE, Bonsel GJ, de Haas M. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands. Transfusion. 2008;48(5):941–52.PubMedCrossRef
6.
Healsmith S, Savoia H, Kane SC. How clinically important are non-D Rh antibodies? Acta Obstet Gynecol Scand. 2019;98(7):877–84. .PubMedCrossRef
7.
Chen C, Tan J, Wang L, Han B, Sun W, Zhao L, Huang C, Tan B, Qin L. Unexpected red blood cell antibody distributions in Chinese people by a systematic literature review. Transfusion. 2016;56(4):975–9. .PubMedCrossRef
8.
Yang R, Li G, He X, Ren M. Analysis of neonatal hemolytic disease caused by Rh, MNS blood type system irregular antibodies[article in Chinese]. J Clin Hematol. 2019;32(01):109–12. .
9.
Yang X, Chen FZ, Hong Q. Analysis of Screening Results in 501 Newborns with Hemolytic Disease[article in Chinese]. J Exp Hematol Chin. 2019;27(1):192–6.
10.
Phung TV, Houfflin-Debarge V, Ramdane N, Ghesquiere L, Delsalle A, Coulon C, Subtil D, Vaast P, Garabedian C. Maternal red blood cell alloimmunization requiring intrauterine transfusion: a comparative study on management and outcome depending on the type of antibody. Transfusion. 2018;58(5):1199–205. .PubMedCrossRef
11.
Moise KJ Jr. Management of rhesus alloimmunization in pregnancy. Obstet Gynecol. 2008;112(1):164–76.PubMedCrossRef
12.
Mari G, Norton ME, Stone J, Berghella V, Sciscione AC, Tate D, Schenone MH, Med SM-F. Society for Maternal-Fetal Medicine (SMFM) Clinical Guideline #8: The fetus at risk for anemia-diagnosis and management. Am J Obstet Gynecol. 2015;212(6):697–710.PubMedCrossRef
13.
Webb J, Delaney M. Red Blood Cell Alloimmunization in the Pregnant Patient. Transfus Med Rev. 2018;32(4):213–9.PubMedCrossRef
14.
Wu Y, Liu Y, Liu X, Liu J, Wu Y, Chen B, Liang Y. Distribution of irregular antibodies of erythrocyte blood group in 30 800 Han patients and 4200 pregnant women. J Fourth Mil Med Univ[article in Chinese]. 2007;28(10):922–5.
15.
Kaushansky K, Lichtman MA, Prchal JT, Levi MM, Press OW, Burns LJ, Caligiuri M. Williams Hematology. 9 ed. New York: McGraw-Hill Education; 2015.
16.
Yu Y, Ma C, Sun X, Guan X, Zhang X, Saldanha J, Chen L, Wang D. Frequencies of red blood cell major blood group antigens and phenotypes in the Chinese Han population from Mainland China. Int J Immunogenet. 2016;43(4):226–35.PubMedCrossRef
17.
Li XF, Diao XQ, Liu XL, Lv HJ, Cui ZH. Study on the implication of anti-K antibody in hemolytic disease of the newborn-one case report[article in Chinese]. Chin J Blood Transfus. 2015;28(9):1115–7.
18.
Stetson B, Scrape S, Markham KB. Anti-M Alloimmunization: Management and Outcome at a Single Institution. Am J Perinatol Rep. 2017;7(4):e205–10.CrossRef
19.
Yasuda H, Ohto H, Nollet KE, Kawabata K, Saito S, Yagi Y, Negishi Y, Ishida A. Hemolytic disease of the fetus and newborn with late-onset anemia due to anti-M: a case report and review of the Japanese literature. Transfus Med Rev. 2014;28(1):1–6.PubMedCrossRef
20.
Gao XY, Huang H, Li LD. Hemolytic disease of neonates due to anti-M: report of one case and review of reports of 21 cases [article in Chinese]. Chin J Pediatr. 2009;47(9):648–52.
21.
Li S, Mo C, Huang L, Shi X, Luo G, Ji Y, Fang Q. Hemolytic disease of the fetus and newborn due to alloanti-M: three Chinese case reports and a review of the literature. Transfusion. 2019;59(1):385–95.PubMedCrossRef
22.
Ishida A, Ohto H, Yasuda H, Negishi Y, Tsuiki H, Arakawa T, Yagi Y, Uchimura D, Miyazaki T, Ohashi W, et al. Anti-M antibody induced prolonged anemia following hemolytic disease of the newborn due to erythropoietic suppression in 2 siblings. J Pediatr Hematol Oncol. 2015;37(6):375–7.CrossRef
23.
Nolan B, Hinchliffe R, Vora A. Neonatal pure red cell aplasia due to maternal anti-M. Blood. 2000;96(11):8A. .
24.
Markham KB, Rossi KQ, Nagaraja HN, O’Shaughnessy RW. Hemolytic disease of the fetus and newborn due to multiple maternal antibodies. Am J Obstet Gynecol. 2015;213(1):68.e61-e65.CrossRef
25.
Spong CY, Porter AE, Queenan JT. Management of isoimmunization in the presence of multiple maternal antibodies. Am J Obstet Gynecol. 2001;185(2):481–4.PubMedCrossRef
26.
Nordvall M, Dziegiel M, Hegaard HK, Bidstrup M, Jonsbo F, Christensen B, Hedegaard M. Red blood cell antibodies in pregnancy and their clinical consequences: synergistic effects of multiple specificities. Transfusion. 2009;49(10):2070–5. .PubMedCrossRef
27.
Walsh CA, Russell N, McAuliffe FM, Higgins S, Mahony R, Carroll S, McParland P. Relationship between maternal antibody type and antenatal course following intrauterine transfusion for red cell alloimmunisation. Eur J Obstet Gynecol Reprod Biol. 2013;171(2):235–9.PubMedCrossRef
28.
Wikman A, Edner A, Gryfelt G, Jonsson B, Henter JI. Fetal hemolytic anemia and intrauterine death caused by anti-M immunization. Transfusion. 2007;47(5):911–7. .PubMedCrossRef
29.
Fasano RM, Hendrickson JE, Luban NLC. Alloimmune Hemolytic Disease of the Fetus and Newborn. In: Kaushansky K, Lichtman MA, Prchal JT, Levi MM, Press OW, Burns LJ, Caligiuri M, editors. Williams Hematology. 9e ed. New York: McGraw-Hill Education; 2015. .
30.
Hu JP, Liu J, Xue FM, Halverson G, Reid M, Guo AQ, Chen LX, Raza A, Galili N, Jaffray J, et al. Isolation and functional characterization of human erythroblasts at distinct stages: implications for understanding of normal and disordered erythropoiesis in vivo. Blood. 2013;121(16):3246–53.PubMedPubMedCentralCrossRef
Metadata
Title
Distribution of maternal red cell antibodies and the risk of severe alloimmune haemolytic disease of the foetus in a Chinese population: a cohort study on prenatal management
Authors
Si Li
Zhiming He
Yanmin Luo
Yanli Ji
Guangping Luo
Qun Fang
Yu Gao
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Pregnancy and Childbirth / Issue 1/2020
Electronic ISSN: 1471-2393
DOI
https://doi.org/10.1186/s12884-020-03235-w

Other articles of this Issue 1/2020

BMC Pregnancy and Childbirth 1/2020 Go to the issue

Research article

Potential factors associated with institutional childbirth among women in rural villages of Lao People’s Democratic Republic: a preliminary study

Research article

Measurement of maternal functioning during pregnancy and postpartum: findings from the cross-sectional WHO pilot study in Jamaica, Kenya, and Malawi

Research article

Healthy pregnancies and essential fats: focus group discussions with Zambian women on dietary need and acceptability of a novel RUSF containing fish oil DHA

Research article

Maternal coffee intake and the risk of bleeding in early pregnancy: a cross-sectional analysis

Research article

Communication in high risk ante-natal consultations: a direct observational study of interactions between patients and obstetricians

Research article

Bimanual examination for clot evacuation: a retrospective cohort study of women with postpartum haemorrhage after vaginal delivery